Year in Review: Evolving Landscape in Multiple Myeloma | Supplements And Featured Publications

Dr. Raje on Data With AMG 420 in Multiple Myeloma

March 18, 2020

Noopur Raje, MD, director, Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, and professor of medicine, Harvard Medical School, discusses data with AMG 420 in multiple myeloma.

Dr. Morgan on BCMA-Targeted ADCs in Multiple Myeloma

March 18, 2020

Gareth J. Morgan, MD, PhD, a professor in the Department of Medicine and director of Multiple Myeloma Research, NYU Langone Health’s Perlmutter Cancer Center, discusses BCMA-targeted antibody-drug conjugates (ADCs) in multiple myeloma.

Dr. Lonial on Data With Belantamab Mafodotin in Multiple Myeloma

March 11, 2020

Sagar Lonial, MD, FACP, professor and chair, Department of Hematology and Medical Oncology, Emory University School of Medicine, chief medical officer, Winship Cancer Institute of Emory University, discusses data with belantamab mafodotin in multiple myeloma.

x